Disc Medicine, Inc.: comprehensive income or loss

What this measure means

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Exact concept: us-gaap:ComprehensiveIncomeNetOfTax. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2023-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Disc Medicine, Inc.: total assets
• Disc Medicine, Inc.: total liabilities
• Disc Medicine, Inc.: stockholders equity
• Disc Medicine, Inc.: cash and cash equivalents
• Disc Medicine, Inc.: net income or loss
• Disc Medicine, Inc.: operating cash flow
• Disc Medicine, Inc.: capital expenditure payments
• Disc Medicine, Inc.: financing cash flow
• Disc Medicine, Inc.: investing cash flow
• Disc Medicine, Inc.: retained earnings or deficit
• Disc Medicine, Inc.: basic weighted-average shares
• Disc Medicine, Inc.: diluted weighted-average shares
• Disc Medicine, Inc.: basic earnings per share
• Disc Medicine, Inc.: diluted earnings per share
• Disc Medicine, Inc.: income tax expense or benefit
• Disc Medicine, Inc.: net property, plant and equipment
• Disc Medicine, Inc.: share-based compensation expense
• Disc Medicine, Inc.: operating income or loss
• Disc Medicine, Inc.: current assets
• Disc Medicine, Inc.: current liabilities
• Disc Medicine, Inc.: current accounts payable
• Disc Medicine, Inc.: operating expenses
• Disc Medicine, Inc.: selling, general and administrative expense
• Disc Medicine, Inc.: research and development expense
• Disc Medicine, Inc.: common shares outstanding
• Disc Medicine, Inc.: cash including restricted cash
• Disc Medicine, Inc.: additional paid-in capital
• Disc Medicine, Inc.: accumulated other comprehensive income or loss
• Disc Medicine, Inc.: operating lease right-of-use asset
• Disc Medicine, Inc.: operating lease liability
• Disc Medicine, Inc.: long-term debt
• Disc Medicine, Inc.: accumulated depreciation on property, plant and equipment
• Disc Medicine, Inc.: other noncurrent assets
• Disc Medicine, Inc.: accrued current liabilities
• Disc Medicine, Inc.: prepaid expenses and other current assets
• Disc Medicine, Inc.: net deferred tax assets
• Disc Medicine, Inc.: pre-tax income or loss from continuing operations
• Disc Medicine, Inc.: profit or loss including noncontrolling interests
• Disc Medicine, Inc.: net income available to common stockholders
• Disc Medicine, Inc.: general and administrative expense
• Disc Medicine, Inc.: depreciation expense
• Disc Medicine, Inc.: depreciation, depletion and amortization
• Disc Medicine, Inc.: nonoperating interest expense
• Disc Medicine, Inc.: other nonoperating income or expense
• Disc Medicine, Inc.: nonoperating income or expense
• Disc Medicine, Inc.: interest paid, net
• Disc Medicine, Inc.: income taxes paid, net
• Disc Medicine, Inc.: proceeds from issuing common stock
• Disc Medicine, Inc.: operating lease payments
• Disc Medicine, Inc.: change in accounts payable

Inspect the source

Entity

Disc Medicine, Inc. / CIK 0001816736

Captured

2026-09-21T17:28:50.686Z

SEC response SHA-256

421e104e527f147326319d8b61f8431e4fb5fd50582b6fa5a33306dca338477e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001816736.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))